Literature DB >> 17825251

Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea.

Hiroyuki Sato1, Cédric Genet, Axelle Strehle, Charles Thomas, Annelise Lobstein, Alain Wagner, Charles Mioskowski, Johan Auwerx, Régis Saladin.   

Abstract

Olive tree (Olea europeaea) leaves are well known for their effect on metabolism in particular as a traditional anti-diabetic and anti-hypertensive herbal drug. These properties are until now only attributed to oleuropein, the major secoiridoid of olive leaves. Here we describe the isolation and the identification of another constituent implicated in the anti-diabetic effect of this plant, i.e. oleanolic acid. We show that this triterpene is an agonist for TGR5, a member of G-protein coupled receptor activated by bile acids and which mediates some of their various cellular and physiological effect. Oleanolic acid lowers serum glucose and insulin levels in mice fed with a high fat diet and it enhances glucose tolerance. Our data suggest that both oleuropein and oleanolic acid are involved in the anti-diabetic effect of olive leaves and further emphasize the potential role of TGR5 agonists to improve metabolic disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825251     DOI: 10.1016/j.bbrc.2007.06.130

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  83 in total

Review 1.  Role of bile acids in the regulation of the metabolic pathways.

Authors:  Hiroki Taoka; Yoko Yokoyama; Kohkichi Morimoto; Naho Kitamura; Tatsuya Tanigaki; Yoko Takashina; Kazuo Tsubota; Mitsuhiro Watanabe
Journal:  World J Diabetes       Date:  2016-07-10

2.  A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes.

Authors:  Shuai Xue; Jianli Yin; Jiawei Shao; Yuanhuan Yu; Linfeng Yang; Yidan Wang; Mingqi Xie; Martin Fussenegger; Haifeng Ye
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

3.  Differential action of TGR5 agonists on GLP-2 secretion and promotion of intestinal adaptation in a piglet short bowel model.

Authors:  Sen Lin; Barbara Stoll; Jason Robinson; Jose J Pastor; Juan C Marini; Ignacio R Ipharraguerre; Bolette Hartmann; Jens J Holst; Stephanie Cruz; Patricio Lau; Oluyinka Olutoye; Zhengfeng Fang; Douglas G Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

4.  Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway.

Authors:  Senthilkumar Rajagopal; Divya P Kumar; Sunila Mahavadi; Sayak Bhattacharya; Ruizhe Zhou; Carlos U Corvera; Nigel W Bunnett; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

5.  Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling.

Authors:  Anatoliy I Masyuk; Bing Q Huang; Brynn N Radtke; Gabriella B Gajdos; Patrick L Splinter; Tatyana V Masyuk; Sergio A Gradilone; Nicholas F LaRusso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-04-11       Impact factor: 4.052

Review 6.  GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation.

Authors:  T Lieu; G Jayaweera; N W Bunnett
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

7.  Bile Acid Receptors and Liver Cancer.

Authors:  Xichun Wang; Xianghui Fu; Carl Van Ness; Zhipeng Meng; Xiaoxiao Ma; Wendong Huang
Journal:  Curr Pathobiol Rep       Date:  2012-12-21

8.  The TGR5 receptor mediates bile acid-induced itch and analgesia.

Authors:  Farzad Alemi; Edwin Kwon; Daniel P Poole; TinaMarie Lieu; Victoria Lyo; Fiore Cattaruzza; Ferda Cevikbas; Martin Steinhoff; Romina Nassini; Serena Materazzi; Raquel Guerrero-Alba; Eduardo Valdez-Morales; Graeme S Cottrell; Kristina Schoonjans; Pierangelo Geppetti; Stephen J Vanner; Nigel W Bunnett; Carlos U Corvera
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

9.  Bile acid sequestrants for lipid and glucose control.

Authors:  Bart Staels; Yehuda Handelsman; Vivian Fonseca
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

10.  Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes.

Authors:  Scott A Reisman; Lauren M Aleksunes; Curtis D Klaassen
Journal:  Biochem Pharmacol       Date:  2009-04-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.